✦ LIBER ✦

Icatibant, a Potent and Selective Bradykinin B2 Receptor Antagonist, is Effective in Treating Patients with Hereditary Angioedema (HAE)

✍ Scribed by Levy, R.J.; Goodman, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Icatibant, a Selective Bradykinin B2 Rec

✍ RIEDL, M 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Resolution of Symptoms in a Patient with

✍ Boehm, T.; Lumry, W.R. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Self-Administration Of a Novel Subcutane

✍ Santucci, Stephanie; Pham, Hoang; Harrison, Rachel; Yang, William H. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Icatibant, a Selective Bradykinin B2 Rec

✍ Bork, K. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Successful long-term treatment with the

✍ Jens Greve; Thomas K. Hoffmann; Patrick Schuler; Stephan Lang; Adam Chaker; Mura 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Safety Evaluation of Icatibant, a Select

✍ Staubach, P.; Bork, K. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 40 KB